These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 2532634

  • 21. The radiosensitizing effects of hypoxic cell sensitizer on SCCVII tumors in mice evaluated by highly accurate colony formation assay assisted by microcomputer.
    Ono K, Akuta K, Masunaga S, Kinashi Y, Suzuki M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1066-70. PubMed ID: 9014470
    [No Abstract] [Full Text] [Related]

  • 22. [Radiosensitizer: hypoxic cell radiosensitizer].
    Mori T.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
    [Abstract] [Full Text] [Related]

  • 23. The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers.
    Shrieve DC, Harris JW.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jul; 48(1):127-38. PubMed ID: 3159699
    [Abstract] [Full Text] [Related]

  • 24. Radiosensitization of human colorectal tumor cells by 4-nitro-5-sulfonatoimidazoles.
    Fitzpatrick DA, Heindel ND, Egolf RA, Walton H.
    Radiat Res; 1989 Jan; 117(1):47-58. PubMed ID: 2913608
    [Abstract] [Full Text] [Related]

  • 25. Radiosensitizing and cytotoxic effects of nitroimidazoles in CHO cells expressing elevated levels of glutathione-S-transferase.
    Stratford IJ, Hickson ID, Robson CN, Stephens M.
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1307-10. PubMed ID: 2523884
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    DeGraff WG, Russo A, Gamson J, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1021-4. PubMed ID: 2522917
    [Abstract] [Full Text] [Related]

  • 27. Fluorinated 2-nitroimidazole derivative hypoxic cell radiosensitizers: radiosensitizing activities and pharmacokinetics.
    Sasai K, Iwai H, Yoshizawa T, Nishimoto S, Shibamoto Y, Oya N, Shibata T, Abe M.
    Int J Radiat Oncol Biol Phys; 1994 Jun 15; 29(3):579-82. PubMed ID: 8005818
    [Abstract] [Full Text] [Related]

  • 28. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM, Yu NY, Brown JM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1982 Jun 15; 8(3-4):435-8. PubMed ID: 7107364
    [Abstract] [Full Text] [Related]

  • 29. Hyperthermia enhances the cytotoxicity against hypoxic cells of RP-170, a new 2-nitroimidazole nucleoside hypoxic cell sensitizer.
    Emi Y, Maehara Y, Kusumoto T, Baba H, Sakaguchi M, Sugimachi K.
    Oncology; 1995 Jun 15; 52(1):55-9. PubMed ID: 7800343
    [Abstract] [Full Text] [Related]

  • 30. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
    Murayama C, Mori T.
    Gan To Kagaku Ryoho; 1989 Jun 15; 16(6):2135-41. PubMed ID: 2660744
    [Abstract] [Full Text] [Related]

  • 31. Protection against light-activated photofrin II killing of tumor cells by nitroimidazoles.
    Santus R, Stobbe CC, McPhee MS, Chapman JD.
    Radiat Res; 1992 Apr 15; 130(1):31-7. PubMed ID: 1532856
    [Abstract] [Full Text] [Related]

  • 32. Glutathione depletion and cytotoxicity of buthionine sulphoximine and SR2508 in rodent and human cells.
    Ling CC, Wong RS, Basas RD.
    Int J Radiat Oncol Biol Phys; 1990 Feb 15; 18(2):325-30. PubMed ID: 2137437
    [Abstract] [Full Text] [Related]

  • 33. Radiosensitization, pharmacokinetics, and toxicity of a 2-nitroimidazole nucleoside (RA-263).
    Agrawal KC, Rupp WD, Rockwell S.
    Radiat Res; 1986 Feb 15; 105(2):227-39. PubMed ID: 3754053
    [Abstract] [Full Text] [Related]

  • 34. Nitroimidazoles as modifiers of nitrosourea pharmacokinetics.
    Lee FY, Workman P.
    Int J Radiat Oncol Biol Phys; 1984 Sep 15; 10(9):1627-30. PubMed ID: 6237080
    [Abstract] [Full Text] [Related]

  • 35. [Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
    Ono K, Takahashi M, Hamanaka D, Hiraoka M, Nishidai T, Abe M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Feb 25; 43(2):370-6. PubMed ID: 6223274
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of 2-nitroimidazole hypoxic cell radiosensitizers in rodent peripheral nervous tissue.
    Sasai K, Shibamoto Y, Takahashi M, Ito T, Nishimoto S, Abe M.
    Int J Radiat Biol; 1990 May 25; 57(5):971-80. PubMed ID: 1970998
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use.
    Shibamoto Y, Sasai K, Sakaguchi M, Tamulevicius P, Kitakabu Y, Streffer C, Abe M.
    Int J Radiat Biol; 1991 Jan 25; 59(1):105-15. PubMed ID: 1671058
    [Abstract] [Full Text] [Related]

  • 38. SR-2508: a 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use.
    Brown JM, Yu NY, Brown DM, Lee WW.
    Int J Radiat Oncol Biol Phys; 1981 Jun 25; 7(6):695-703. PubMed ID: 6457018
    [No Abstract] [Full Text] [Related]

  • 39. TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
    Kasai S, Nagasawa H, Kuwasaka H, Oshodani T, Nishioka A, Ogawa Y, Yoshida S, Inayama S, Inomata T, Hori H.
    Int J Radiat Oncol Biol Phys; 1998 Nov 01; 42(4):799-802. PubMed ID: 9845099
    [Abstract] [Full Text] [Related]

  • 40. Radiosensitization efficacy of KU-2285, RP-170 and etanidazole at low radiation doses: assessment by in vitro cytokinesis-block micronucleus assay.
    Shibamoto Y, Streffer C, Sasai K, Oya N, Abe M.
    Int J Radiat Biol; 1992 Apr 01; 61(4):473-8. PubMed ID: 1349329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.